Multicenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant pseudomonas aeruginosa

Cargando...
Miniatura

Fecha

Título de la revista

Publicado en

Clinical Infectious Diseases, 1537-6591, Vol. 65, Nro. 1, 2017, p. 158–161

Publicado por

Oxford University Press

Enlace a contenidos multimedia

ISSN de la revista

Título del volumen

Resumen

Descripción

Abstract

A multicenter, retrospective study of patients infected with carbapenem-resistant Pseudomonas aeruginosa who were treated with ceftolozane/tazobactam was performed. Among 35 patients, pneumonia was the most common indication and treatment was successful in 26 (74%). Treatment failure was observed in all cases where isolates demonstrated ceftolozane-tazobactam minimum inhibitory concentrations ≥8 μg/mL.

Palabras clave

Keywords

Ceftolozane, Carbapenem resistant, P. aeruginosa, Multidrug resistant

Temáticas

Citación

Colecciones